Výsledky vyhledávání - Atasoy, Ajlan

Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers Autor Ammannagari, Nischala, Atasoy, Ajlan

Získat plný text Získat plný text Získat plný text

Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey Autor Ozmen, Vahit, Atasoy, Ajlan, Gokmen, Erhan, Ozdogan, Mustafa, Guler, Nilufer, Uras, Cihan, Ok, Engin, Demircan, Orhan, Isikdogan, Abdurrahman, Saip, Pinar

Získat plný text Získat plný text Získat plný text

Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma Autor Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.

Získat plný text Získat plný text Získat plný text

Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey Autor Özmen, Vahit, Atasoy, Ajlan, Gökmen, Erhan, Özdoğan, Mustafa, Güler, Nilufer, Uras, Cihan, Ok, Engin, Demircan, Orhan, Işıkkdoğan, Abdurrahman, Cabioğlu, Neslihan, Şen, Fatma, Saip, Pınar

Získat plný text Získat plný text Získat plný text

Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer Autor Morse, Michael A., Overman, Michael J., Hartman, Leighanne, Khoukaz, Taline, Brutcher, Edith, Lenz, Heinz‐Josef, Atasoy, Ajlan, Shangguan, Tong, Zhao, Huanyu, El‐Rayes, Bassel

Získat plný text Získat plný text Získat plný text

Barrett’s esophagus and animal models Autor Macke, Ryan A., Nason, Katie S., Mukaisho, Ken-ichi, Hattori, Takanori, Fujimura, Takashi, Sasaki, Shozo, Oyama, Katsunobu, Miyashita, Tomoharu, Ohta, Tetsuo, Miwa, Koichi, Zaidi, Ali, Malhotra, Usha, Atasoy, Ajlan, Foxwell, Tyler, Jobe, Blair

Získat plný text Získat plný text Získat plný text